SignalXSignalX

CV CapsoVision, Inc

8-K Current Report
Filed: March 13, 2026
Health Care
Electromedical & Electrotherapeutic Apparatus
CapsoVision, Inc Overview

CapsoVision, Inc (CV) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 1.01: Entry into a Material Definitive Agreement

AI Filing Analysis
8-K

Item 1.01 · Entry into a Material Definitive Agreement

  • • Total Canon development fee raised to ~$5.1M ($4.1M original + $1M amendment) for CMOS image sensor development
  • • Amendment triggered by expanded feature specifications; all other original terms unchanged
+3 more insights

Get deeper insights on CapsoVision, Inc

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.